In the early-1990s, a Bothell, Wash.-based startup called CellPro developed a novel way to clean bone marrow stem cells before inserting them into leukemia patients. Early clinical trials saw surprisingly high rates of survival in desperately ill children, and CellPro’s cancer-stricken CEO also made a bone-marrow-aided comeback in experimental treatment.
When the Klamath Restoration Agreements were signed in February 2010, the documents were hailed as a historic solution to decades of conflicts over water rights and environmental management in the Klamath Basin. Almost two years later, many stakeholders are still waiting to move forward with projects connected to the agreements, which include both the Klamath Basin Restoration Agreement and the Klamath Hydroelectric Settlement Agreement. At issue is whether legislators will authorize the agreements and allocate the $500 million for implementation.
It’s pink, sleek, and form-fitting, the inside lined with a layer of rayon for extra comfort. It costs 30% more than similar products, but research says women will pay it for added comfort. And part of the sales of the $2.99 product will go to the Susan G. Komen Foundation for breast cancer research.